CME Group Inc.
DE ˙ XTRA ˙ US12572Q1058
217,80 € ↑3,15 (1,47%)
2026-06-03
AKTIENPREIS
SecurityDE:MX4A / CME Group Inc.
Institution1832 Asset Management L.P.
Latest Disclosed Ownership1,053,209 shares
Latest Disclosed Value $ 311,065,278
1832 Asset Management L.P. reports 66.50% increase in ownership of MX4A / CME Group Inc.

On May 14, 2026 - 1832 Asset Management L.P. filed a 13F-HR form disclosing ownership of 1,053,209 shares of CME Group Inc. (DE:MX4A) valued at $269,042,239 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 632,575 shares of CME Group Inc.. This represents a change in shares of 66.50% during the quarter. The current value of the position is $229,388,920 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CME GROUP COM 12572Q105 1,053,209 420,634 66.50 311,065 80.07 0.2860
2026-02-13 2025-12-31 13F CME GROUP COM 12572Q105 632,575 173,252 37.72 172,744 39.19 0.1316
2025-11-14 2025-09-30 13F CME GROUP COM 12572Q105 459,323 -4,648 -1.00 124,104 -2.95 0.0980
2025-08-13 2025-06-30 13F CME GROUP COM 12572Q105 463,971 -695,627 -59.99 127,880 -58.43 0.0998
2025-05-14 2025-03-31 13F CME GROUP COM 12572Q105 1,159,598 393,755 51.41 307,630 72.97 0.2796
2025-02-14 2024-12-31 13F CME GROUP COM 12572Q105 765,843 -54,259 -6.62 177,852 -1.72 0.1512
2024-11-13 2024-09-30 13F CME GROUP COM 12572Q105 820,102 -26,205 -3.10 180,956 8.76 0.1377
2024-08-13 2024-06-30 13F CME GROUP COM 12572Q105 846,307 -62,608 -6.89 166,384 -14.97 0.1352
2024-05-14 2024-03-31 13F CME GROUP COM 12572Q105 908,915 138,715 18.01 195,680 20.64 0.1158
2024-02-13 2023-12-31 13F CME GROUP COM 12572Q105 770,200 136,645 21.57 162,204 27.87 0.2336
2023-11-13 2023-09-30 13F CME GROUP COM 12572Q105 633,555 -104,987 -14.22 126,850 -7.30 0.1799
2023-08-14 2023-06-30 13F CME GROUP COM 12572Q105 738,542 114,543 18.36 136,844 14.51 0.2661
2023-05-12 2023-03-31 13F CME GROUP COM 12572Q105 623,999 566,899 992.82 119,508 1,144.75 0.2458
2023-02-15 2022-12-31 13F CME GROUP COM 12572Q105 57,100 24,519 75.26 9,602 66.37 0.0197
2022-11-14 2022-09-30 13F CME GROUP COM 12572Q105 32,581 181 0.56 5,771 -12.98 0.0123
2022-08-15 2022-06-30 13F CME GROUP COM 12572Q105 32,400 4,500 16.13 6,632 1.33 0.0134
2022-05-16 2022-03-31 13F CME GROUP COM 12572Q105 27,900 0 0.00 6,545 1.54 0.0107
2022-02-15 2021-12-31 13F CME GROUP COM 12572Q105 27,900 -2,516 -8.27 6,446 7.36 0.0114
2021-11-15 2021-09-30 13F CME GROUP COM 12572Q105 30,416 -124,841 -80.41 6,004 -81.84 0.0113
2021-08-20 2021-06-30 13F/A-1 CME GROUP COM 12572Q105 155,257 -967,953 -86.18 33,062 -85.70 0.0639
2021-08-16 2021-06-30 13F CME GROUP COM 12572Q105 155,257 -967,953 33,062 0.0640
2021-05-17 2021-03-31 13F CME GROUP COM 12572Q105 1,123,210 -186,583 -14.25 231,162 -1.13 0.4996
2021-02-16 2020-12-31 13F CME GROUP COM 12572Q105 1,309,793 889,890 211.93 233,809 233.31 0.5468
2020-11-16 2020-09-30 13F CME GROUP COM 12572Q105 419,903 78,014 22.82 70,148 25.75 0.1832
2020-08-14 2020-06-30 13F CME GROUP COM 12572Q105 341,889 315,176 1,179.86 55,785 1,091.99 0.1674
2020-05-26 2020-03-31 13F/A-1 CME GROUP COM 12572Q105 26,713 26,713 4,680 0.0169
2019-11-14 2019-09-30 13F CME GROUP COM 12572Q105 0 -64 -100.00 0 -100.00
2019-08-14 2019-06-30 13F CME GROUP COM 12572Q105 64 4 6.67 12 20.00 0.0000
2019-05-15 2019-03-31 13F CME GROUP COM CL A 12572Q105 60 0 0.00 10 -9.09 0.0000
2019-02-14 2018-12-31 13F CME GROUP COM CL A 12572Q105 60 0 0.00 11 10.00 0.0000
2018-11-14 2018-09-30 13F CME GROUP COM CL A 12572Q105 60 -60 -50.00 10 -50.00 0.0000
2018-08-14 2018-06-30 13F CME GROUP COM CL A 12572Q105 120 -215 -64.18 20 -62.96 0.0001
2018-05-15 2018-03-31 13F CME GROUP COM CL A 12572Q105 335 0 0.00 54 10.20 0.0002
2018-02-14 2017-12-31 13F CME GROUP COM CL A 12572Q105 335 -2,002 -85.67 49 -84.14 0.0002
2017-11-14 2017-09-30 13F CME GROUP COM CL A 12572Q105 2,337 2,337 -97.88 309 -96.31 0.0011
2013-11-13 2013-09-30 13F CME GROUP COM 12572Q105 0 -110,300 -100.00 0 -100.00
2013-08-14 2013-06-30 13F CME GROUP COM 12572Q105 110,300 110,300 8,376 0.0367
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.